Wednesday November 25 2009 | Biotechnology feed | All feeds

Sarcoma 37

Download PDF containing detailed information. PDF Version

Image Results

Recent Publications on Sarcoma 37:
Pregnancy and genital sarcoma: a systematic review of the literature. We conducted a literature review to determine the clinical characteristics...	9th October, 2009	University of Maryland School of Medicine, University of Maryland Medical	Am J Perinatol. 2009 Aug;26(7):507-18. Epub 2009 Mar 13. DOI Direct Link
[Alterations of tissue blood supply of experimental animals at malignant tumor growth] The aim of the research was to study tissue blood flow in the dynamics of...	13th May, 2009		Georgian Med News. 2008 Nov;(164):53-7.
Elevation of efficacy of cancer vaccine combined with interferon and inducer of endogeneous interferon synthesis amixin. AIM: To study in vivo efficacy of combined administration of cancer...	4th March, 2009	R.E. Kavetsky Institute of Experimental Pathology, Oncology and	Exp Oncol. 2008 Dec;30(4):319-23.
[Antineoplastic properties of extracellular fructoso-1,6-bisphosphatase of Bacillus subtilis 668 and preparation isolated from cultural liquids of Bacillus subtilis 7025] It was shown for the first time that extracellular FBPase of B. subtilis...	22nd September, 2007		Mikrobiol Z. 2007 May-Jun;69(3):68-73.
[Influence of probiotic subalin on efficiency of antitumor vaccine] Preparation subalin created on the basis of a recombinant strain of B....	13th February, 2007		Mikrobiol Z. 2006 Nov-Dec;68(6):51-8.
→View more research publications.

Press Releases About Sarcoma 37:
China Medical Technologies Receives SFDA Approval for its Leukemia BCR/ABL Fusion Gene Detection FISH Probe	9th November, 2009	China Medical Technologies, Inc.	BEIJING, Nov. 9 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting	6th November, 2009	Oncolytics Biotech Inc.	CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase II study of
November Marks Fifth Annual National Pet Cancer Awareness Month	29th October, 2009	Veterinary Pet Insurance Co.	BREA, Calif., Oct. 29 /PRNewswire/ -- Cancer is not strictly a "human" condition. As the No. 1 disease-related killer of dogs and cats, cancer claims millions of pets each year. This
VA Extends 'Agent Orange' Benefits to More Veterans	13th October, 2009	U.S. Department of Veterans Affairs	-- Soft Tissue Sarcoma (other than Osteosarcoma, Chondrosarcoma, Kaposi's sarcoma, or Mesothelioma) Additional information about Agent Orange and VA's services and programs
Bone Cancer Research Trust Calls for New Treatments for Bone Cancer	18th June, 2009		LONDON, June 18 /PRNewswire/ -- The Bone Cancer Research Trust is calling for new treatments for bone cancers affecting children and young people. This includes osteosarcoma and Ewing's sarcoma,

BioNews Results for Sarcoma 37:
Rumors distort local cancer patient's experience with the nation's top cancer nonprofit	Highland Community News: Nov 13 2009 6:01PM Matching: sarcoma 37
American cancer doctors reach out to Africa	Boston Herald: Oct 28 2009 12:51AM Matching: sarcoma 37
American cancer doctors reach out to Africa	Bellingham Herald: Oct 28 2009 3:32PM Matching: sarcoma 37
American cancer doctors reach out to Africa	Tri-City Herald Online: Oct 27 2009 9:14AM Matching: sarcoma 37
American cancer doctors reach out to Africa	Augusta Chronicle: Oct 27 2009 6:12AM Matching: sarcoma 37
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Sarcoma 37 Patents:
US Patent No.	Title
7410656	Anti-cancer compounds
6080741	Arglabin compounds and therapeutic uses thereof
6020365	Arglabin compounds and therapeutic uses thereof
5902809	Arglabin compounds and therapeutic uses thereof
5858988	Poly-substituted-phenyl-oligoribo nucleotides having enhanced stability and membrane permeability and methods of use
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Sarcoma 37 scientists - we have details of around 37 individuals working on Sarcoma 37 .

This page has been viewed 245 times
Recent Search Terms used to find this page: arglabin | Elevation of efficacy of cancer vaccine combined with interferon and inducer of endogeneous interferon synthesis amixin | arglabin | subalin wikipedia | arglabin | sarcoma 37 | Arglabin wikipedia | arglabin wikipedia | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Sarcoma 37 across BioPortfolio, or for Sarcoma 37 Research Reports

Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

Sarcoma 37

Image Results

Recent Publications on Sarcoma 37:

Press Releases About Sarcoma 37:

BioNews Results for Sarcoma 37:

Sarcoma 37 Patents: